Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 16.162\% hERG inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] O=C1CN(Cc2ccccc2)C(=NCc2ccco2)S1
[b] CCn1c2ccccc2c2cc(N=C3SC(CC(=O)Nc4ccccc4)C(=O)N3C)ccc21
Answer: b. CCn1c2ccccc2c2cc(N=C3SC(CC(=O)Nc4ccccc4)C(=O)N3C)ccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1c2ccccc2c2cc(N=C3SC(CC(=O)Nc4ccccc4)C(=O)N3C)ccc21
CCn1c2ccccc2c2cc(N=C3SC(CC(=O)Nc4ccccc4)C(=O)N3C)ccc21
2-[2-(9-ethylcarbazol-3-yl)imino-3-methyl-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide